;

:

–

Kang SS, Wong PW, Norusis M. Homocysteinemia due to folate deficiency. Metabolism,

;

:

–

Brattstro¨m L, Israelsson B, Lindgarde F, Hultberg B. Higher total plasma homocysteine in vitamin B

deficiency than in heterozygosity for homocystinuria due to cystathionine beta- synthase deficiency. Metabolism,

;

:

–

Ubbink JB, van der Merwe A, Delport R et al. The effect of

Our finding that gender is not associated with the mutation is consistent with other studies [12,25,46] as is

subnormal vitamin B-

status on homocysteine metabolism. J Clin Invest,

;

:

–

Kang SS, Wong PW, Susmano A, Sora J, Norusis M, Ruggie N. Thermolabile methylenetetrahydrofolate reductase: an inherited risk factor for coronary artery disease. Am J Hum Genet,

;

:

–

Goyette P, Sumner JS, Milos R et al. Human methylenetetrahydrofolate reductase: isolation of

NA mapping and mutation identification. Nat Genet,

;

:

Frosst P, Blom HJ, Milos R et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet,

;

:

–

Jacques PF, Bostom AG, Williams RR et al. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation,

;

:

–

Arruda VR, von Zuben PM, Chiaparini LC, Annichino- Bizzacchi JM, Costa FF. The mutation Ala

! Val in the methylene tetrahydrofolate reductase gene: a risk factor for arterial disease and venous thrombosis. Thromb Haemost,

;

:

–

Cattaneo M, Tsai MY, Bucciarelli P et al. A common mutation in the methylenetetrahydrofolate reductase gene (C

T) increases the risk for deep-vein thrombosis in patients with mutant factor V (factor V:Q

). Arterioscler Thromb Vasc Biol

;

:

–

Gallagher PM, Meleady R, Shields DC et al. Homocysteine and risk of premature coronary heart disease. Evidence for a common gene mutation. Circulation,

;

:

–

Izumi M, Iwai N, Ohmichi N, Nakamura Y, Shimoike H, Kinoshita M. Molecular variant of

,

- methylenetetrahydrofolate reductase is a risk factor of ischemic heart disease in the Japanese population. Atherosclerosis,

;

:

–

Kluijtmans LA, van den Heuvel LP, Boers GH et al. Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am J Hum Genet,

;

:

–

Kluijtmans LA, Kastelein JJ, Lindemans J et al. Thermolabile methylenetetrahydrofolate reductase in coronary artery disease. Circulation,

;

:

–

Morita H, Taguchi J, Kurihara H et al. Genetic polymorphism of

,

-methylenetetrahydrofolate reductase (MTHFR) as a risk factor for coronary artery disease. Circulation,

;

:

–

Cordoba A, Circra S, Carrascosa R. Thermolabile genotype of methylenetetrahydrofolate reductase (MTHFR) and hyperhomocysteinaemia in patients with nonhaemorrhagic cerebro vascular disease. J Inherit Metabol Dis,

;

(Suppl.

):

Markus HS, Ali N, Swaminathan R, Sankaralingam A, Molloy J, Powell J. A common polymorphism in the methylenetetrahydrofolate reductase gene, homocysteine, and ischemic cerebrovascular disease. Stroke,

;

:

–

Kluijtmans LA, den Heijer M, Reitsma PH, Heil SG, Blom HJ, Rosendaal FR. Thermolabile methylenetetrahydrofolate reductase and factor V Leiden in the risk of deep-vein thrombosis. Thromb Haemost,

;

:

–

Tosetto A, Missiaglia E, Frezzato M, Rodeghiero F. The VITA project: C

T mutation in the methylene-

tetrahydrofolate reductase gene and risk of venous thromboembolism. Br J Haematol,

;

:

–

Deloughery TG, Evans A, Sadeghi A et al. Common mutation in methylenetetrahydrofolate reductase. Correlation with homocysteine metabolism and late-onset vascular disease. Circulation,

;

:

–

Adams M, Smith PD, Martin D, Thompson JR, Lodwick D, Samani NJ. Genetic analysis of thermolabile methylenetetrahydrofolate reductase as a risk factor for myocardial infarction. Q J Med,

;

:

–

Anderson JL, King GJ, Thomson MJ et al. A mutation in the methylenetetrahydrofolate reductase gene is not associated with increased risk for coronary artery disease or myocardial infarction. J Am Coll Cardiol,

;

:

–

Brattstro¨m L, Wilcken DE, Ohrvik J, Brudin L. Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a meta-analysis. Circulation,

;

:

–

Brugada R, Marian AJ. A common mutation in methylenetetrahydrofolate reductase gene is not a major risk of coronary artery disease or myocardial infarction. Atherosclerosis,

;

:

–

Chadefaux-Vekemans B, Kara Mostefa A, Thuillier L. Does the prevalent mutation

C!T in the methylenetetrahydrofolate reductase gene account for hyperhomocysteinaemia related to cardiovascular disease. J Inherit Metabol Dis,

;

(Suppl.

):

Christensen B, Frosst P, Lussier-Cacan S et al. Correlation of a common mutation in the methylenetetrahydrofolate reductase gene with plasma homocysteine in patients with premature coronary artery disease. Arterioscler Thromb Vasc Biol,

;

:

–

de Franchis R, Mandato C, Sebastio G. Moderate hyperhomocysteinaemia (HHC) and C

T mutation of methylenetetrahydrofolate reductase (MTHFR) gene as a risk factor for atherosclerotic cardiovascular disease and neural tube defects in Italy. J Inherit Metabol Dis,

;

(Suppl.

):

Ma J, Stampfer MJ, Hennekens CH et al. Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians. Circulation,

;

:

–

Reinhardt D, Sigusch HH, Vogt SF, Farker K, Muller S, Hoffmann A. Absence of association between a common mutation in the methylenetetrahydrofolate reductase gene and the risk of coronary artery disease. Eur J Clin Invest,

;

:

–

Schmitz C, Lindpaintner K, Verhoef P, Gaziano JM, Buring J. Genetic polymorphism of methylenetetrahydrofolate reductase and myocardial infarction. A case-control study. Circulation,

;

:

–